Loading...
•
Dec 31, 2023
Evolus Q4 2023 Earnings Report
Evolus achieved record revenue and made strides toward profitability.
Key Takeaways
Evolus reported a record fourth quarter global net revenue of $61.0 million, representing a 40% increase compared to the same period last year. The company also generated $0.8 million of cash from operating activities and significantly reduced its non-GAAP operating loss to $3.7 million.
Global net revenue reached a record $61.0 million, a 40% increase year-over-year.
Generated $0.8M of Cash from Operating Activities.
Non-GAAP operating loss improved to $3.7 million, the lowest since inception.
Accounts purchasing Jeuveau® increased by a record high of more than 840.
Forward Guidance
Evolus expects total net revenues for the full year 2024 to be between $255 and $265 million and expects to achieve positive non-GAAP operating income on a consolidated basis for the fourth quarter of 2024 and for the full year 2025.
Positive Outlook
- Evolus expects total net revenues for the full year 2024 to be between $255 and $265 million, representing year-over-year growth of 26% to 31% from 2023 results and well above the estimated growth rate of the aesthetic neurotoxin market.
- Evolus expects its adjusted gross profit margin for the full year 2024 to be between 68% and 71%, consistent with 2023 guidance.
- Evolus expects its full-year non-GAAP operating expenses to be between $185 and $190 million.
- The company expects to achieve positive non-GAAP operating income on a consolidated basis for the fourth quarter of 2024 and for the full year 2025.
- The company projects its total net revenue can reach at least $700 million by 2028, a compound annual growth rate of 28% from 2023, based on the combination of its existing aesthetic neurotoxin business and anticipated launch of the Evolysse™ HA dermal filler product line beginning in 2025.
Challenges Ahead
- Within the year 2025, profitability may not be sustained every quarter due to the filler launch.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...